Contract to be Jointly Administered by Linear Health Sciences and GS2 Global
OKLAHOMA CITY, Okla.–(BUSINESS WIRE)–#IVdislodgement—Linear Health Sciences, a medical device company that has developed a proprietary, breakaway safety valve platform, today announced that it was awarded a contract by the U.S. Dept. of Veterans Affairs (VA) for its Orchid SRV tension-activated breakaway safety release valve, in partnership with GS2. The contract is defined as a Federal Supply Schedule with VA/Department of Defense access.
The Orchid SRV is a sterile, single-use connector for needle-free access that makes return to treatment fast, simple, and clean, and improves both the patient and clinician experience. Clinical simulation testing of 360 Orchid SRVs showed that the device prevented IV dislodgement by 91.9 percent across all test groups. The device is placed between the existing IV extension set and general IV tubing connection intended to be used for delivery of fluids to and from an IV catheter.
“This contract allows the VA system to evaluate and adopt the Orchid SRV in a patient population that can directly benefit from its function,” said Dan Clark, co-founder and CEO of Linear Health Sciences. “It’s a significant step toward providing our veterans with the gold-standard level of care they deserve.”
According to a study published in J-AVA, 95 percent of 1,561 U.S. clinicians surveyed agreed that IV dislodgement continues to pose safety risks for patients and hospitals. Of the 342 million peripheral IVs deployed in the U.S. each year1, up to 10 percent may dislodge2, costing more than $2 billion annually3. Dislodgement is most frequently caused by patient confusion or removal of the catheter, loose dressing or tape, or tubing becoming tangled in bed linens.
“This device is innovative, saves hospitals money, and increases customer service and quality of care for all patients who need an IV. Veterans deserve the best technology offered on the market today. The Orchid falls into this category, as it’s simply a superior product, and should be in stock at every VA hospital,” said GS2 Global CEO Blaine Hedges.
The Orchid SRV has also received an Innovative Technology contract from Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company, and was recently awarded a national group purchasing agreement for the IV Therapy – Needleless Connectors category with Premier, Inc.
About Linear Health Sciences
Linear Health Sciences is a medical device company that has developed a proprietary, breakaway safety valve technology designed to improve the use of medical tubing in hospitals. The platform technology was developed to increase the safety and satisfaction of patients, caregivers, and healthcare facilities, while dramatically reducing costs. The company’s initial products include the Orchid SRV for use in IV catheter therapy and the Orchid SRV Type D device for use in surgical/wound, nephrostomy and abscess drainage. For more information, visit linearsciences.com.
1 iData research report
2 “The Peripheral Intravenous Catheter Journey: A Prospective Cohort Study of 1000 Patients.” Podium presentation
3 Helm, et al. “Accepted but unacceptable: peripheral IV catheter failure” J Infus Nurs May-Jun 2015;38(3):189-203. doi: 10.1097/NAN.0000000000000100
Contacts
Sam Choinski
Pazanga Health Communications
[email protected]
(860) 301-5058